Agent for reducing the number of intestinal bacteria, food, and pharmaceutical product
US-10398745-B2 · Sep 3, 2019 · US
US11602702B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11602702-B2 |
| Application number | US-202016832098-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2020 |
| Priority date | Sep 29, 2017 |
| Publication date | Mar 14, 2023 |
| Grant date | Mar 14, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a method for producing a purified Salacia genus plant extract having improved flavor by increasing the α-glucosidase inhibitory activity of the extract without significantly reducing the recovery rate of the extract concomitantly with purification; and a purified Salacia genus plant extract. The method for producing a purified Salacia genus plant extract includes an extraction step of bringing a Salacia genus plant-containing raw material extract including at least one of a Salacia genus plant, a Salacia genus plant extract, and a Salacia genus plant ground product, into contact with 0.1 to 20 mass % of activated carbon in the presence of an extraction solvent.
Opening claim text (preview).
What is claimed is: 1. A method for producing a purified Salacia genus plant extract, the method comprising an extraction step of bringing a Salacia genus plant-containing raw material extract comprising at least one of a Salacia genus plant, a Salacia genus plant extract, or a Salacia genus plant ground product, into contact with 0.1 to 20 mass % of activated carbon in the presence of an extraction solvent, wherein the purified Salacia genus plant extract has a content of the sum of polyphenols and lipids of less than 10 mass % with respect to the total amount of the purified Salacia genus plant extract. 2. The method for producing a purified Salacia genus plant extract according to claim 1 , wherein the time for bringing the Salacia genus plant-containing raw material extract into contact with the activated carbon is 5 minutes to 5 hours. 3. The method for producing a purified Salacia genus plant extract according to claim 1 , wherein water at 10° C. to 100° C. is used as the extraction solvent. 4. The method for producing a purified Salacia genus plant extract according to claim 1 , wherein the activated carbon has a specific surface area of 500 to 2,500 m 2 /g and an average pore diameter of 0.5 to 10 nm. 5. The method for producing a purified Salacia genus plant extract according to claim 1 , wherein the content of epicatechin with respect to the total amount of the purified Salacia genus plant extract is less than 0.004 mass %.
obtained by solvent extraction · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.